Part 11 of Title 21 of the Code of Federal Regulation was passed by the FDA in 1997 and established standards for the use of electronic records and signatures. Many companies in the pharmaceutical, medical device, biotechnology and services industries are finding themselves challenged to ensure regulatory compliance through all their operations due to their lack of understanding the full impact of 21 CFR Part 11 on Information Systems. Once a clear picture of the scope of the CFR is understood, companies will find compliance as not just another regulatory exercise but an opportunity to incorporate technology into the current business processes.
Areas Covered in the Session:
Who Will Benefit: The employee who will benefit include: